Arch Point Investors Bristol Myers Squibb CO Transaction History

Arch Point Investors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $236,079 - $275,213	-4,402 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $260,466 - $305,102	4,402 New	4,402 $263,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $55,719 - $60,678	-900 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $38,048 - $55,292	-820 Reduced 47.67%	900 $50,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $3.33 Million - $4.15 Million	-65,859 Reduced 97.45%	1,720 $95,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $8,988 - $10,347	-150 Reduced 0.22%	67,579 $4.27 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $59 - $68	1 Added 0.0%	67,729 $4.15 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $59 - $65	-1 Reduced -0.0%	67,728 $4.15 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $3.74 Million - $4.32 Million	67,729	67,729 $4.32 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

Stay updated on Arch Point Investors with notifications on news.